Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome
- 1Department of Radiology, Affiliated Hospital of North Sichuan Medical College, 637000 Nanchong, Sichuan, China
- 2Nuclear Medicine and Radiation Safety Key Laboratory of Sichuan Province, North Sichuan Medical College, 637000 Nanchong, Sichuan, China
Abstract
Background:: Patients with schizophrenia (SCZ) are at a markedly increased risk of developing metabolic syndrome (MetS), which substantially reduces life expectancy and adversely affects treatment adherence. Although cognitive impairment is a core feature of SCZ, the neurobiological mechanisms linking comorbid MetS to cognitive dysfunction remain complex and incompletely understood. Previous studies have primarily focused on the effects of abnormal brain function and white matter abnormalities on cognition, whereas the contribution of gray matter volume (GMV) alterations in the context of comorbid MetS has received comparatively less attention. Accordingly, this study examined GMV alterations in patients with SCZ and comorbid MetS and evaluated whether these alterations mediate the association between MetS and cognitive impairment.
Methods:: Sixty clinically stable patients with SCZ receiving risperidone or clozapine were recruited, including 28 meeting the diagnostic criteria for MetS (SCZ-MetS) and 32 without MetS (SCZ-nMetS), together with 31 demographically matched healthy controls (HCs). High-resolution structural magnetic resonance imaging (MRI) scans were analyzed using voxel-based morphometry (VBM) to quantify GMV. Mediation analyses were performed to determine whether GMV alterations mediated the association between MetS and cognitive function.
Results:: Compared with the HC group, both the SCZ-nMetS and SCZ-MetS groups exhibited widespread GMV reductions involving the cingulate cortex, left temporal lobe, frontal regions, and insula. Compared with the SCZ-nMetS group, the SCZ-MetS group showed significantly reduced GMV in the right superior orbitofrontal gyrus, as well as in the left amygdala, left insula, and temporal lobe (p < 0.05). Mediation analysis indicated that reduced GMV in the right superior orbitofrontal gyrus significantly mediated the association between MetS and deficits in executive function (p < 0.05).
Conclusions:: MetS-related executive dysfunction may be partly associated with reduced GMV in the right superior orbitofrontal gyrus, suggesting a potential mediating role of this brain region.
Related
- Causal relationship between liver fat reduction and clinical outcomes in human genetic studies and randomized clinical trials of metabolic-dysfunction associated steatohepatitis
- Accelerated brain aging associated with executive deficits in adolescence and early adulthood among individuals with schizophrenia and genetic high risk
- Executive dysfunction in COPD: prevalence and clinical correlates of cognitive impairment : A cross-sectional case–control study
- Updating deficits in subjective cognitive decline: A differential pattern of executive dysfunction across clinical stages.
- Neuroscience-Informed Psychoeducation for Schizophrenia: From Circuit Dysfunction to Insight and Functional Recovery
BibTeX
@article{li2026right,
title = {{Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome}},
author = {Hangyu Li and Xinyan Wu and Xinyue Chen and Ying Li and Shiji Peng and Rui Yu and Nian Liu},
journal = {Alpha Psychiatry},
year = {2026},
month = oct,
doi = {10.31083/ap52539},
url = {https://doi.org/10.31083/ap52539},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Right Superior Orbitofrontal Gray Matter Volume Reduction Mediates Executive Dysfunction in Schizophrenia Patients With Comorbid Metabolic Syndrome
AU - Hangyu Li
AU - Xinyan Wu
AU - Xinyue Chen
AU - Ying Li
AU - Shiji Peng
AU - Rui Yu
AU - Nian Liu
PY - 2026
DA - 2026/10/16
JO - Alpha Psychiatry
DO - 10.31083/ap52539
UR - https://doi.org/10.31083/ap52539
AB - Background:: Patients with schizophrenia (SCZ) are at a markedly increased risk of developing metabolic syndrome (MetS), which substantially reduces life expectancy and adversely affects treatment adherence. Although cognitive impairment is a core feature of SCZ, the neurobiological mechanisms linking comorbid MetS to cognitive dysfunction remain complex and incompletely understood. Previous studies have primarily focused on the effects of abnormal brain function and white matter abnormalities on cognition, whereas the contribution of gray matter volume (GMV) alterations in the context of comorbid MetS has received comparatively less attention. Accordingly, this study examined GMV alterations in patients with SCZ and comorbid MetS and evaluated whether these alterations mediate the association between MetS and cognitive impairment. Methods:: Sixty clinically stable patients with SCZ receiving risperidone or clozapine were recruited, including 28 meeting the diagnostic criteria for MetS (SCZ-MetS) and 32 without MetS (SCZ-nMetS), together with 31 demographically matched healthy controls (HCs). High-resolution structural magnetic resonance imaging (MRI) scans were analyzed using voxel-based morphometry (VBM) to quantify GMV. Mediation analyses were performed to determine whether GMV alterations mediated the association between MetS and cognitive function. Results:: Compared with the HC group, both the SCZ-nMetS and SCZ-MetS groups exhibited widespread GMV reductions involving the cingulate cortex, left temporal lobe, frontal regions, and insula. Compared with the SCZ-nMetS group, the SCZ-MetS group showed significantly reduced GMV in the right superior orbitofrontal gyrus, as well as in the left amygdala, left insula, and temporal lobe (p < 0.05). Mediation analysis indicated that reduced GMV in the right superior orbitofrontal gyrus significantly mediated the association between MetS and deficits in executive function (p < 0.05). Conclusions:: MetS-related executive dysfunction may be partly associated with reduced GMV in the right superior orbitofrontal gyrus, suggesting a potential mediating role of this brain region.
SN - 2757-8038
ER -